Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium

被引:1
|
作者
Zhang, WB
Kapusta, LR
Slingerland, JM
Klotz, LH
机构
[1] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Urol, Toronto, ON M4N 3M5, Canada
[2] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Pathol, Toronto, ON M4N 3M5, Canada
[3] Univ Toronto, Sunnybrook Hlth Sci Ctr, Div Canc Biol Res, Toronto, ON M4N 3M5, Canada
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Telomerase is a ribonucleoprotein that synthesizes telomeric DNA on chromosomal ends, Telomerase activation has been seen in many immortal cell lines and cancers, Telomerase activity was analyzed in prostate carcinoma; in coexistent prostatic intraepithelial neoplasia (PIN), benign prostatic hyperplasia (BPH), atrophy and normal tissue; and in benign prostate glands, Telomerase activity was detected in 80 of 87 (92%) prostate cancers, Forty-one matched samples (from a total of 32 cases) were available for comparative analysis, The presence of telomerase activity in adjacent PIN, BPH, and normal tissue was correlated with telomerase activity in the malignant epithelium. In these adjacent tissues, telomerase activity was found in 11 of 15 (73%) PINs, 13 of 26 (50%) BPHs, and 1 of 6 (16%) atrophy and 4 of 11 (36%) normal tissues, In contrast to the BPH tissue from cancer-bearing glands, all 16 BPH specimens from patients only diagnosed with BPH were telomerase activity negative, In cancer samples, there was no correlation between telomerase activity and Gleason grade or preoperation prostate-specific antigen level, Our data indicate that telomerase activity is present in most prostate cancers. The high rate of telomerase activity in the benign-appearing areas of these glands may be attributed either to the presence of occult cancer cells or to early molecular alterations of cancer that were histologically inapparent.
引用
收藏
页码:619 / 621
页数:3
相关论文
共 50 条
  • [1] Telomeres and telomerase in prostatic intraepithelial neoplasia and prostate cancer biology
    Meeker, AK
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2006, 24 (02) : 122 - 130
  • [2] Telomerase as a Tumor Marker in Diagnosis of Prostatic Intraepithelial Neoplasia and Prostate Cancer
    Glybochko, P. V.
    Zezerov, E. G.
    Glukhov, A. I.
    Alyaev, Yu. G.
    Severin, S. E.
    Polyakovsky, K. A.
    Varshavsky, V. A.
    Severin, E. S.
    Vinarov, A. Z.
    PROSTATE, 2014, 74 (10): : 1043 - 1051
  • [3] Prostatic intraepithelial neoplasia and prostate cancer
    Montironi, R
    Santinelli, A
    Mazzucchelli, R
    PANMINERVA MEDICA, 2002, 44 (03) : 213 - 220
  • [4] Expression of PDX-1 in prostate cancer, prostatic intraepithelial neoplasia and benign prostatic tissue
    Jonmarker, Sara
    Glaessgen, Axel
    Culp, W. David
    Pisa, Pavel
    Lewensohn, Rolf
    Ekman, Peter
    Valdman, Alexander
    Egevad, Lars
    APMIS, 2008, 116 (06) : 491 - 498
  • [5] PSA IN BENIGN PROSTATIC HYPERPLASIA AND PROSTATIC INTRAEPITHELIAL NEOPLASIA
    ELLIS, WJ
    BRAWER, MK
    UROLOGIC CLINICS OF NORTH AMERICA, 1993, 20 (04) : 621 - 625
  • [6] The expression of thrombospondin-1 in benign prostatic hyperplasia and prostatic intraepithelial neoplasia is decreased in prostate cancer
    Vallbo, C
    Wang, W
    Damber, JE
    BJU INTERNATIONAL, 2004, 93 (09) : 1339 - 1343
  • [8] Prostatic intraepithelial neoplasia in dogs with spontaneous prostate cancer
    Waters, DJ
    Hayden, DW
    Bell, FW
    Klausner, JS
    Qian, JQ
    Bostwick, DG
    PROSTATE, 1997, 30 (02): : 92 - 97
  • [9] Telomere DNA damage links benign prostatic hypertrophy, intraepithelial neoplasia, and prostate cancer
    Wu, Jianchun
    Crowe, David L.
    CANCER RESEARCH, 2018, 78 (13)
  • [10] MICROCIRCULATION IN PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN) AND TYPICAL BENIGN HYPERPLASIA OF THE PROSTATE
    BIGLER, SA
    BRAWER, MK
    DEERING, RE
    BROWN, M
    LABORATORY INVESTIGATION, 1993, 68 (01) : A56 - A56